The international generalisability of evidence for health policy: A cross country comparison of medication adherence following policy change

详细信息    查看全文

• 作者：Sarah-Jo Sinnott^a ; ^{sarahjosinnott@lshtm.ac.uk} ; Helen Whelton^b ; Jessica Myers Franklin^c ; Jennifer Milan Polinski^c
• 关键词：Pharmaceutical policy ; Cost sharing ; Medication adherence ; Generalisability
• 刊名：Health Policy
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：121
• 期：1
• 页码：27-34
• 全文大小：636 K
• 卷排序：121

文摘

How generalisable is evidence for health policy making across health systems, in particular evidence for prescription copayments? We addressed this question by studying two similar copayment policies in two health systems. We assessed the impact of each policy on adherence. These two similar copayment policies did not invoke similar responses in adherence to medications. Nuanced differences between the health systems and the patients within them may affect differences in impact of policies. Before applying evidence from one health system to another, critical questions about local applicability are key to maximising its’ utility.